High court denied interim relief to Merck
After the news that Novartis failed to secure an Indian patent for Glivec, the patenting woes of Western pharma in India seem to continue as Merck are denied interim relief in a patent case against Glenmark. The decision came within days of Merck’s subsidiary, MSD India, dragging the domestic company to court over the [...]